Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus INPERSOL LC LM W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER vs INPERSOL-LC/LM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal Low Calcium with Dextrose 1.5% is a peritoneal dialysis solution that provides osmotic gradient for ultrafiltration and diffusion of solutes across the peritoneal membrane. Dextrose (1.5%) acts as the osmotic agent, creating a concentration gradient that drives water removal. The low calcium concentration (2.5 mEq/L) helps manage hypercalcemia in patients requiring calcium-based phosphate binders.
Inpersol-LC/LM with dextrose 1.5% is a peritoneal dialysis solution. The mechanism involves instillation into the peritoneal cavity, where dextrose creates an osmotic gradient that drives ultrafiltration of fluid and removal of uremic toxins (e.g., urea, creatinine) across the peritoneal membrane. The low calcium (LC) and low magnesium (LM) formulation helps prevent hypercalcemia and hypermagnesemia.
Intraperitoneal administration: 2 L per exchange, 4 exchanges per day (2.5 L per exchange for larger patients if tolerated).
Intraperitoneal administration: For continuous ambulatory peritoneal dialysis (CAPD), instill 2 liters of 1.5% dextrose solution into the peritoneal cavity via a permanent indwelling catheter. Exchange 4 times per day (every 6 hours) with a dwell time of 4-6 hours. For automated peritoneal dialysis (APD), typical regimen includes 2 liters per cycle with 4-5 cycles overnight and a daytime dwell.
None Documented
None Documented
For intraperitoneal dextrose: not clinically applicable as elimination is via continuous peritoneal dialysis. Systemically absorbed dextrose has a half-life of 15-20 minutes due to rapid cellular uptake and metabolism.
Not applicable via systemic absorption; glucose absorbed from dialysate exhibits a terminal half-life of 1.5–2 hours in plasma, reflecting rapid cellular uptake and metabolism.
Primarily removed via peritoneal dialysis itself; ~70% of absorbed glucose undergoes metabolism, with remaining glucose and lactate absorbed systemically and metabolized hepatically. Renal elimination of dextrose and lactate is negligible (<5%) due to low systemic absorption and endogenous metabolism.
Renal: negligible; primarily eliminated via peritoneal dialysis (dialysate outflow). Biliary/fecal: <1%.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution